Gene · 7296
Papers4,270
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
261 to 280 of 4,270
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Identification of key genes and signaling pathways of liver cancer and model construction for prognosis and diagnosis based on bioinformatics analysis. | PLoS One | 2025 | 40465781 | PubTator, text mining | PubMed |
| CRISPR screen reveals a simultaneous targeted mechanism to reduce cancer cell selenium and increase lipid oxidation to induce ferroptosis. | Proc Natl Acad Sci U S A | 2025 | 40445760 | PubTator, text mining | PubMed |
| Comparative proteomics and structure-based approach to unravel the therapeutic drug target of Theileria species. | J Genet Eng Biotechnol | 2025 | 40390487 | PubTator, text mining | PubMed |
| Surveying Enzyme Crystal Structures Reveals the Commonality of Active-Site Solvent Accessibility and Enzymatic Water Networks. | ACS Omega | 2025 | 40385134 | PubTator, text mining | PubMed |
| Redox shuttle of cytosolic Thioredoxin to mitochondria protects against hyperoxia-mediated alteration of mitochondrial structure and dysfunction. | Redox Biol | 2025 | 40382797 | PubTator, text mining | PubMed |
| Reactive Oxygen Species: From Tumorigenesis to Therapeutic Strategies in Cancer. | Cancer Med | 2025 | 40377005 | PubTator, text mining | PubMed |
| Recent insights into the biosynthesis and biological activities of the peptide-derived redox cofactor mycofactocin. | Nat Prod Rep | 2025 | 40375824 | PubTator, text mining | PubMed |
| Engineering catalytically promiscuous enzymes to serve new functions. | Biotechnol Adv | 2025 | 40374085 | PubTator, text mining | PubMed |
| Interaction of glaucocalyxin a with glutathione and thioredoxin reductase for triple-negative breast cancer treatment. | Bioorg Chem | 2025 | 40359839 | PubTator, text mining | PubMed |
| Utilizing Nanopore direct RNA sequencing of blood from patients with sepsis for discovery of co- and post-transcriptional disease biomarkers. | BMC Infect Dis | 2025 | 40355874 | PubTator, text mining | PubMed |
| Distinct roles for the thioredoxin and glutathione antioxidant systems in Nrf2-Mediated lung tumor initiation and progression. | Redox Biol | 2025 | 40334547 | PubTator, text mining | PubMed |
| A F420-dependent Single Domain Chemogenetic Tool for Protein De-dimerization. | J Mol Biol | 2025 | 40324743 | PubTator, text mining | PubMed |
| Oxidative Electrocyclization Assembles 2,2-Dimethyl-2H-pyran in Fungal Indole Alkaloids. | Angew Chem Int Ed Engl | 2025 | 40305423 | PubTator, text mining | PubMed |
| Comparative Genomic and Transcriptomic Analysis Provides New Insights into the Aflatoxin B1 Biodegradability by Kocuria rosea from Deep Sea. | Microorganisms | 2025 | 40284711 | PubTator, text mining | PubMed |
| Self-Cascade of the Cu/Ce-MOF-808 Nanozyme for One-Step Colorimetric Sensing. | Anal Chem | 2025 | 40214028 | PubTator, text mining | PubMed |
| Stable isotope probing and oligotyping reveal the impact of organophosphorus pesticides on the carbon fixation related bacterioplankton lineage. | J Hazard Mater | 2025 | 40187249 | PubTator, text mining | PubMed |
| Crystal structure and polymorphic forms of auranofin revisited. | RSC Adv | 2025 | 40182499 | PubTator, text mining | PubMed |
| Caffeic acid activates Nrf2 enzymes, providing protection against oxidative damage induced by ionizing radiation. | Brain Res Bull | 2025 | 40174789 | PubTator, text mining | PubMed |
| Production optimization, characterization, and application of a novel thermo- and pH-stable laccase from Bacillus drentensis 2E for bioremediation of industrial dyes. | Int J Biol Macromol | 2025 | 40158574 | PubTator, text mining | PubMed |
| Catalytic preference-enabled exclusive bimodal detection of methyl-paraoxon in complex food matrices using double site-synergized organophosphorus hydrolase-mimetic fluorescent nanozymes. | Food Chem | 2025 | 40158368 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7296/papers?page=14